Skip to main content
SpringerLink
Log in

Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity

  • Research Articles
  • Drug Actions
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The protective effect of eugenol and its possible mechanisms were investigated in rats with acute doxorubicin cardiotoxicity. Cardiac toxicity was induced by a single intraperitoneal injection of doxorubicin (20 mg/kg). Eugenol treatment (5 mg/kg/day, orally) was started 2 days before doxorubicin administration and continued for five consecutive days. Eugenol significantly reduced the elevated serum creatine kinase and lactate dehydrogenase levels, and restored the electrocardiographic disturbances resulted from doxorubicin administration. Also, eugenol reversed doxorubicin-induced deficits in the antioxidant defense mechanisms, decreased lipid peroxidation and attenuated the elevations in cytosolic Ca2+ and nitric oxide levels in cardiac tissue. In addition, doxorubicin-induced cardiac tissue damage observed by histopathological examination was markedly ameliorated with eugenol. Immunohistochemical analysis revealed that eugenol prevented the doxorubicin-induced activation of caspase-3 in cardiomyocytes. The cardioprotective effect afforded by eugenol was not significantly inhibited by prior administration of capsazepine, the transient potential vanilloid receptor-1 antagonist. It was concluded that eugenol, through its antioxidant activity and its ability to reduce cardiac Ca2+ accumulation and nitric oxide levels, is a potential candidate to protect against acute doxorubicin cardiotoxicity, a major and dose-limiting clinical problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abraham, S. K., Anti-genotoxicity of trans-anethole and eugenol in mice. Food Chem. Toxicol., 39, 493–498 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Andreadou, I., Sigala, F., Iliodromitis, E. K., Papaefthimiou, M., Sigalas, C., Aligiannis, N., Savvari, P., Gorgoulis, V., Papalabros, E., and Kremastinos, D. T., Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J. Mol. Cell. Cardiol., 42, 549–558 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Burkey, J. L., Sauer, J. M., McQueen, C. A., and Sipes, I. G., Cytotoxicity and genotoxicity of methyleugenol and related congeners-a mechanism of activation for methyleugenol. Mutat. Res., 453, 25–33 (2000).

    PubMed  CAS  Google Scholar 

  • Choi, C. Y., Park, K. R., Lee, J-.H., Jeon, Y. J., Liu, K. H., Oh, S., Kim, D. E., and Yea, S. S., Isoeugenol suppression of inducible nitric oxide synthase expression is mediated by down-regulation of NF-B, ERK1/2, and p38 kinase. Eur. J. Pharmacol., 576, 151–159 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Choudhary, R., Mishra, K. P., and Subramanyam, C., Interrelations between oxidative stress and calcineurin in the attenuation of cardiac apoptosis by eugenol. Mol. Cell. Biochem., 283, 115–122 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Franco-Cereceda, A., Saria, A., and Lundberg, J. M., Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain. Acta Physiol. Scand., 135, 173–187 (1989).

    Article  PubMed  CAS  Google Scholar 

  • Huang, R., Karve, A., Shah, I., Bowers, M. C., DiPette, D. J., Supowit, S. C., and Abela, G. S., Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol., 294, H1291–H1297 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Jiang, B., Zhang, L., Li, M., Wu, W., Yang, M., Wang, J., and Guo, D.-a., Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress. Food Chem. Toxicol., 46, 1510–1515 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Ito, M., Murakami, K., and Yoshino, M., Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food Chem. Toxicol., 43, 461–466 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Kabuto, H., Tada, M., and Kohno, M., Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. Biol. Pharm. Bull., 30, 423–427 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Keung, E. C., Toll, L., Ellis, M., and Jensen, R. A., L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations. J. Clin. Invest., 87, 2108–2113 (1991).

    Article  PubMed  CAS  Google Scholar 

  • Kim, S. Y., Kim, S. J., Kim, B. J., Rah, S. Y., Chung, S. M., Im, M. J., and Kim, U. H., Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes. Exp. Mol. Med., 38, 535–545 (2006).

    PubMed  CAS  Google Scholar 

  • Li, H. Y., Park, C. K., Jung, S. J., Choi, S. Y., Lee, S. J., Park, K., Kim, J. S., and Oh, S. B., Eugenol inhibits K+ currents in trigeminal ganglion neurons. J. Dent. Res., 86, 898–902 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Li, W., Tsubouchi, R., Qiao, S., Haneda, M., Murakami, K., and Yoshino, M., Inhibitory action of eugenol compounds on the production of nitric oxide in RAW264.7 macrophages. Biomed. Res., 27, 69–74 (2006).

    Article  PubMed  Google Scholar 

  • Li, Y. J. and Peng, J., The cardioprotection of calcitonin gene-related peptide-mediated preconditioning. Eur. J. Pharmacol., 442, 173–177 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Magyar, J., Szentandrássy, N., Bányász, T., Fülöp, L., Varró, A., and Nánási, P. P., Effects of terpenoid phenol derivatives on calcium current in canine and human ventricular cardiomyocytes. Eur. J. Pharmacol., 487, 29–36 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Manzini, S., Perretti, F., De Benedetti, L., Pradelles, P., Maggi, C. A., and Geppetti, P., A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release. Br. J. Pharmacol., 97, 303–312 (1989).

    PubMed  CAS  Google Scholar 

  • Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., and Gianni, L., Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev., 56, 185–229 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Mizutani, T., Satoh, K., and Nomura, H., Hepatotoxicity of eugenol and related compounds in mice depleted of glutathione: structural requirements for toxic potency. Res. Commun. Chem. Pathol. Pharmacol., 73, 87–95 (1991).

    PubMed  CAS  Google Scholar 

  • Morsy, M. A. and Fouad, A. A., Mechanisms of gastroprotective effect of eugenol in indomethacin-induced ulcer in rats. Phytother. Res., 22, 1361–1366 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Nagababu, E., Sesikeran, B., and Lakshmaiah, N., The protective effects of eugenol on carbon tetrachloride induced hepatotoxicity in rats. Free Radic. Res., 23, 617–627 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Ou, H. C., Chou, F. P., Lin, T. M., Yang, C. H., and Sheu, W. H.-H., Protective effects of eugenol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells. Food Chem. Toxicol., 44, 1485–1495 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Pacher, P., Liaudet, L., Bai, P., Mabley, J. G., Kaminski, P. M., Virág, L., Deb, A., Szabó, E., Ungvári, Z., Wolin, M. S., Groves, J. T., and Szabó, C., Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation, 107, 896–904 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Sayed-Ahmed, M. M., Khattab, M. M., Gad, M. Z., and Osman, A. M., Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy. Pharmacol. Toxicol., 89, 140–144 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Singal, P. K. and Iliskovic, N., Doxorubicin-induced cardiomyopathy. N. Engl. J. Med., 339, 900–905 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Singh, G., Singh, A. T., Abraham, A., Bhat, B., Mukherjee, A., Verma, R., Agarwal, S. K., Jha, S., Mukherjee, R., and Burman, A. C., Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity. J. Ethnopharmacol., 117, 123–129 (2008).

    Article  PubMed  Google Scholar 

  • Thompson, D. C., Constantin-Teodosiu, D., and Moldéus, P., Metabolism and cytotoxicity of eugenol in isolated rat hepatocytes. Chem. Biol. Interact., 77, 137–147 (1991).

    Article  PubMed  CAS  Google Scholar 

  • Thompson, D. C., Barhoumi, R., and Burghardt, R. C., Comparative toxicity of eugenol and its quinone methide metabolite in cultured liver cells using kinetic fluorescence bioassays. Toxicol. Appl. Pharmacol., 149, 55–63 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Tiku, A. B., Abraham, S. K., and Kale, R. K., Eugenol as an in vivo radioprotective agent. J. Radiat. Res., 45, 435–440 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Wang, L., Hu, C. P., Deng, P. Y., Shen, S. S., Zhu, H. Q., Ding, J. S., Tan, G. S., and Li, Y. J., The protective effects of rutaecarpine on gastric mucosa injury in rats. Planta Med., 71, 416–419 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Yang, B. H., Piao, Z. G., Kim, Y.-B., Lee, C.-H., Lee, J. K., Park, K., Kim, J. S., and Oh, S. B., Activation of vanilloid receptor 1 (VR1) by eugenol. J. Dent. Res., 82, 781–785 (2003).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences, Division of Pharmacology, College of Medicine, Al-Ahsa, King Faisal University, 31982, Al-Ahsa, Saudi Arabia

    Amr A. Fouad

  2. Department of Biomedical Sciences, Division of Pathology, College of Medicine, Al-Ahsa, King Faisal University, Al-Ahsa, Saudi Arabia

    Mohamed T. Yacoubi

Authors
  1. Amr A. Fouad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed T. Yacoubi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amr A. Fouad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fouad, A.A., Yacoubi, M.T. Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity. Arch. Pharm. Res. 34, 821–828 (2011). https://doi.org/10.1007/s12272-011-0516-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-011-0516-2

Key words

Search

Navigation